Kyverna Therapeutics, Inc. (KYTX)
(Delayed Data from NSDQ)
$4.35 USD
-0.45 (-9.38%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $4.36 +0.01 (0.23%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/25/25 |
---|---|
Current Quarter | -0.95 |
EPS Last Quarter | -0.80 |
Last EPS Surprise | -3.90% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.39 |
Next Year | -4.06 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | 0.00M | 7.03M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.95 | -0.90 | -3.39 | -4.06 |
# of Estimates | 4 | 2 | 4 | 4 |
Most Recent Consensus | -0.70 | -0.72 | -3.01 | -2.99 |
High Estimate | -0.70 | -0.72 | -3.01 | -2.99 |
Low Estimate | -1.03 | -1.07 | -3.54 | -4.51 |
Year ago EPS | NA | -1.12 | -89.61 | -3.39 |
Year over Year Growth Est. | NA | 19.64% | 96.22% | -19.84% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.95 | -0.90 | -3.39 | -4.06 |
7 Days Ago | -0.95 | -0.90 | -3.39 | -4.06 |
30 Days Ago | -0.95 | -0.90 | -3.39 | -4.06 |
60 Days Ago | -0.95 | -0.90 | -3.39 | -4.06 |
90 Days Ago | -0.98 | -0.95 | -3.49 | -4.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.95 | -0.90 | -3.39 | -4.06 |
Zacks Consensus Estimate | -0.95 | -0.90 | -3.39 | -4.06 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.80 | -0.67 | -1.12 | NA | NA |
Estimate | -0.77 | -0.70 | -0.88 | NA | NA |
Difference | -0.03 | 0.03 | -0.24 | NA | -0.08 |
Surprise | -3.90% | 4.29% | -27.27% | NA | -8.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more